Key result
Soluble ST2 is a blood protein induced in mechanically overloaded cardiac myocytes that may serve as an early marker for cardiovascular diseases, particularly heart failure and ischemic heart disease.
Why the study?
Does soluble ST2 measurement improve the early detection of cardiovascular diseases such as heart failure and ischemic heart disease?
Does soluble ST2 measurement improve the early detection of cardiovascular diseases such as heart failure and ischemic heart disease?
Soluble ST2 is highlighted as a promising biomarker for detecting mechanical overload and early stages of heart failure and ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
May aid early HF and MI detection in practice; extends biomarker evidence beyond BNP and troponins.
Ciccone et al. (2013) conducted a review in Cardiovascular diseases, heart failure, ischemic heart diseases. Soluble ST2 was evaluated on Role of ST2 derived-protein as an early marker of cardiovascular diseases. Soluble ST2 is a blood protein induced in mechanically overloaded cardiac myocytes that may serve as an early marker for cardiovascular diseases, particularly heart failure and ischemic heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: